Introduction {#s1}
============

Apple is an important fruit crop in temperate regions of the world. The use of dwarfing rootstocks and high density planting of apple trees is common in commercial orchards as it increases yields per unit area and reduces the cost of management practices, such as pruning. The use of spur-type scion varieties is one of effective methods used to facilitate high-density planting, along with the use of dwarfing rootstocks.

"Fuji" is the major cultivar planted in China, accounting for more than 65% of apple plantings. Several spontaneous "Fuji" spur-type mutants have been identified and utilized in the breeding and planting of "Fuji" apples. The spur-type growth habit in apple is characterized by a reduced number of vegetative shoots and a corresponding increase in the number of fruiting spurs, short distances between nodes, compact and dense growth, and dark green and relatively thick leaves (Lapins and Lapins, [@B24]). Spur-type apple trees exhibit a high rate of bud break but have weak branching, characterized by rosette foliage and overall reduced levels of vegetative growth. The anatomical structure of spur-type shoots is characterized by vessel elements that are shorter and narrower than in standard-type shoots. The spur-type vessel elements have longer ends (tails), and thicker secondary cell walls (Yang et al., [@B50]).

Several earlier studies have reported that spur-type apple trees have lower levels of GA than standard-type trees, are less sensitive to applications of GA, and have reduced rates of conversion of GA19 to GA20 under high temperature conditions in summer (Steffens and Hedden, [@B43]; Song et al., [@B42]). The majority of shoot elongation is the result of cell expansion, with gibberellins playing a dominant role in this process. GAs promote internode elongation and overall shoot elongation by regulating cell proliferation, differentiation, and expansion. The "green revolution," semi-dwarf varieties of cereal crops, are defective in GA biosynthesis and/or signaling. Auxin is recognized as the major hormone involved in shoot development (Gallavotti, [@B15]). Auxin also influences stem elongation and regulates the formation, activity, and fate of meristems. Cytokinins (CK) inhibit the differentiation of cells in the SAM and instead promotes cell division. CK promotes SAM enlargement partly through WUSCHEL, and defects in CK synthesis or perception reduces the size of the SAM size (Leibfried et al., [@B27]; Kyozuka, [@B23]). Except for GA, however, the levels of plant hormones in spur-type apples have not been reported or are unclear.

MicroRNAs (miRNAs) are a class of endogenous 20--24 nt non-coding RNAs. In plants, miRNAs are transcribed by RNA polymerase II, 5′ capped, spliced, and polyadenylated at the 3′ end to create pri-miRNAs. DICER-LIKE (DCL) protein processes the stem-loop structure in pri-miRNAs, creating pre-miRNA, and subsequently miRNA/miRNA^\*^ duplexes. A single mature miRNAs is generated by the removal of the miRNA^\*^. The mature miRNA is recruited into a RISC complex (RISC) which degrades mRNA targets or suppresses their translation. Plant miRNAs play a critical role in growth, organ development, phase changes, senescence, fruit ripening, stress response, disease resistance, stress tolerance, and mineral assimilation and translocation.

Some miRNAs in plants have been shown to regulate plant architecture. A point mutation in *OsSPL14* perturbs the cleavage of *OsSPL14* transcripts by OsmiR156, which affects tiller number and lodging resistance, as and enhances grain yield (Jiao et al., [@B21]). OsmiR397 down regulates a laccase-like protein *OsLAC* involved in brassinosteroid sensitivity, and thereby promotes panicle branching (Zhang et al., [@B54]). OsMIR444 participates in a miRNA/MADS/TCP/D14 (miMTD) regulation module, in which D14 functions in strigolactone (SL) signaling to control tillering, by suppressing *OsMADS57* expression (Guo et al., [@B18]). In pear trees, miR6390 is involved in the transition from endormancy to ecodormancy by targeting *PpDAM* transcripts, degrading them and stimulating the release of *PpFT2* (Niu et al., [@B34]). Overexpression of the *MbDRB1*, a gene involved in miRNA biogenesis in *Malus baccata*, increased the level of adventitious rooting, curly leaf, and columnar-like architecture (You et al., [@B51]).

The molecular mechanisms responsible for spur-type architecture is unclear. Few studies have been conducted on the role of miRNAs in the architecture of fruit trees. In the present study, miRNA and degradome sequencing was used to identify miRNA involved in shoot development in *Malus domestica* "Nagafu 2" and spur bud mutation "Yanfu 6." Morphological indicies, plant hormone levels, miRNA, and target gene expression, and the application of various hormone treatments were also measured and/or used to compare and contrast shoot development in "Yanfu 6" vs. "Nagafu 2." This comprehensive analysis was conducted in order to identify and determine the potential role of miRNA-mediated regulatory network in shoot growth and involvement of miRNA in the architecture of fruit trees and other woody, perennial plants.

Materials and methods {#s2}
=====================

Plant materials
---------------

Experiments were conducted in 2013 and 2014 using standard-type "Nagafu 2" and spur-type mutant "Yanfu 6" apple (*Malus domestica*) trees that were grafted on Malling "M.26" rootstocks and planted in 2009. Trees were located in the experimental plots of the Yangling National Apple Improvement Center, Yangling, China (34.31° N, 108.04° E), trained and managed using standard horticultural practices. The meteorological conditions of the experiment site in 2013 and 2014 are described in Figure [S1](#SM1){ref-type="supplementary-material"}. Three biological replicates consisting of five trees of each genotype were used, for a total of 15 trees.

Apical portions (5--8 mm below and including the shoot meristem) of YF and CF shoots (without any leaves or petiole tissue), were collected at 45 days after bud break (DABB) in 2013 and used for deep miRNA sequencing. Similar apical portions of shoots were also collected at 65, 85, 105, 125, and 145 DABB in 2013 for miRNA and mRNA expression analysis. Approximately 30 shoot samples of each biological replicate of YF and CF were collected. Leaves near the shoot tips were also collected for plant hormone measurements. All samples were immediately frozen in liquid nitrogen and stored at −80°C for subsequent RNA and hormone extraction.

Measurement of tree growth
--------------------------

Six individual shoots on each of six trees were marked in each genotype to assess shoot elongation on a weekly basis in 2013 and 2014. The number of internodes present on each shoot were also recorded. Internode lengths were estimated by dividing the overall shoot length by the number of internodes.

Hormone measurements
--------------------

Approximately 0.5 g of leaf samples were used to measure IAA, GA, ZR, and ABA. The plant hormones were extracted using the method described by Dobrev and Kamınek ([@B19]) and Dobrev et al. ([@B11]), quantifed by the High Pressure Liquid Chromatography (Waters, USA) and enzyme-linked immunosorbent assay.

GA treatment
------------

YF and CF trees were sprayed with 500 mg·L^−1^ GA~4+7~ at the end of April 2014. Shoot tips, as previously described, were subsequently sampled at 0, 2, 4, 6, and 8 days after spraying. Both shoot length and internode length were also recorded.

Small RNA and degradome sequencing
----------------------------------

Total RNA was isolated using the CTAB method (Chang et al., [@B6]). After ligating adaptors to the 5′ and 3′ RNA, the purified RNAs were reverse transcribed using primers with partial complementarity to the adaptors. The DNA pool amplified from the first-strand cDNA was subsequently sequenced using a Hiseq 2000 (Illumina, San Diego, CA) sequencer located at the Beijing Genomics Institute (BGI), Shenzhen.

The YF sample for miRNA sequencing was also subjected to degradome sequencing in order to better determine the miRNA/mRNA pairing relationship. For the construction of the degradome libraries, a 5′ RNA adapter with a *Mme* I recognition site was ligated to the 5′ terminus of purified polyA RNA. The 5′ ligated products were reverse transcribed using five PCR cycles, digested with *Mme* I, and ligated to a 3′ double DNA adapter. Lastly, the ligated products were amplified by PCR and gel-purified for deep sequencing.

The miRNA and degradome sequencing raw data were available at NCBI SRA (BioProject ID: PRJNA361540).

Bioinformatic analysis of miRNA
-------------------------------

The original sequence data from the sequencing machine were used for basic analysis. Filtering the low quality reads and contaminants sequence (adaptor, polyA, reads shorter than 18 nt, insert tag, reads without 3′ primer) and discarding the remaining reads with lengths smaller than 18 nt, the clean reads were used for the advanced analysis. The length distribution of the clean reads were summarized to analyze the compositions of small RNA sample. Unique tags and total tags existence among the sample were summarized to verify whether the uniformity of the two samples on the whole of sequencing was good.

The small RNA tags were mapped to the apple reference genome at GDR (<http://www.rosaceae.org>) (Jung et al., [@B22]) using SOAP software to analyze their distribution in the genome and their expression levels. All unique, clean reads, particularly the non-redundant reads, were subjected to further analysis. The clean tags were queried against the known apple miRNAs in the mirBASE 18.0 (<http://www.mirbase.org>) database in order to identify known microRNAs based on the following criteria: (1) the tags aligned to a miRNA precursor in the mirBASE database with no mismatch, and; (2) based on the first criteria, the tags aligned to mature miRNA in the mirBASE database with at least 16 nt overlap, allowing offsets. The unmatched unique reads in each sample were screened in Genbank in order to annotate non-coding RNA sequences (rRNA, scRNA, snoRNA, snRNA, and tRNA). Differentially expressed miRNAs were identified by comparing the sequencing reads between CF and YF and determining statistically significant differences (*P* \< 0.05 and *P* \< 0.01). miRNAs with more than one normalized read were analyzed by calculating their fold-change and *p* values. miRNAs with *p* \< 0.05 and fold changes (log~2~) less than −1 or greater than 1 were considered to have significantly altered expression.

Prediction of miRNA targets and functional annotation
-----------------------------------------------------

The psRNATarget server (<http://plantgrn.noble.org/psRNATarget/>) with default parameters was used to predict putative targets of the identified apple miRNAs. All of the identified apple miRNA were used as a query against "*Malus domestica* (apple), predicted consensus gene set CDS sequences, version 1" database located on the psRNATarget server.

For the degradome sequencing raw data about 50 nt length obtained from HiSeq sequencing, go through steps likely adaptor, pollution, low quality trimmed to obtain "clean" sequence. After a series of annotation of the degradated sequence, the degradation mRNA obtained go through comparison with miRNA to find mRNA-miRNA pairing.

GO enrichment and KEGG pathway analysis
---------------------------------------

GO enrichment and KEGG pathway analysis for all of the annotated miRNAs and their targets, using the apple reference genome background, were conducted in order to predict the function of the miRNA and their targets. Blast2GO was employed to store information from the GO and KEGG pathway databases. All of the miRNA targets were queried against the GO protein database (<http://www.geneontology.org/>) using BLASTX. A combined query was used in order to complete the GO annotation and pathway analysis against the GO and KEGG databases.

Quantitative real-time PCR validation of microRNA and mRNA expression
---------------------------------------------------------------------

Stem-loop RT-qPCR method was used to quantify miRNA expression (Chen et al., [@B7]). mRNAs of the target genes were also quantified. *5S rRNAs* were used as an internal reference of miRNA expression. *MdActin* and *MdEF* were used as internal references for mRNA expression. The primers utilized are listed in Tables [S12](#SM14){ref-type="supplementary-material"}, [S13](#SM15){ref-type="supplementary-material"}. miRNA and mRNA relative expression were calculated using the comparative ΔΔ*CT* method (Livak and Schmittgen, [@B30]).

Statistical analysis
--------------------

The data were analyzed using Data Processing System (DPS, version 7.05; Zhejiang University, Hangzhou, China) software. Significant differences were determined using a Student\'s *t*-test at (*p* ≤ 0.05).

Results {#s3}
=======

Growth characteristics of YF and CF
-----------------------------------

The shoot length in YF was significantly shorter than in CF (Figures [1A,E](#F1){ref-type="fig"}). YF also had shorter internodes, that were approximately 66% shorter than CF (Figures [1C,D](#F1){ref-type="fig"}). Most YF shoots stopped growing between 80 and 105 DABB, which was earlier than CF shoots. After 105 DABB, any continued growth of YF shoots extended their length with a section of shorter internodes.

![**Growth characteristics of CF and YF. (A)** Shoot length. **(B)** Internode number. **(C)** Internode length. **(D)** Shoot of Nagafu 2 (CF) and Yanfu 6 (YF). **(E)** Four-year-old branch of YF and CF. ^\*^ indicates *P* \< 0.05, Student\'s *t*-test; Error bars indicate SE; Scale bars in **(D,E)**, 1 cm.](fpls-08-00441-g0001){#F1}

Plant hormone analyses
----------------------

IAA in YF leaves near the shoot tips was higher than CF leaves at 45 DABB. In contrast, IAA levels in YF were significantly lower than CF at 125 and 145 DABB (Figure [2A](#F2){ref-type="fig"}). The GA content in YF leaves remained at a consistently low level, relative to CF, throughout the entire growth period (Figure [2B](#F2){ref-type="fig"}). The ABA content in YF was significantly lower than CF at 65 and 85 DABB (Figure [2C](#F2){ref-type="fig"}). The ZR content in YF was significantly lower than CF at 45, 65, 125, and 145 DABB (Figure [2D](#F2){ref-type="fig"}). The changes in the levels of the growth promoting hormones, IAA, GA, and ZR, were in accordance with the growth of shoot, namely, exhibiting a high content in the level during the rapid growth period, and a low level as the growth period waned (Figure [2](#F2){ref-type="fig"}). The stress hormone ABA exhibited the opposite trend, exhibiting a low level during the active growth period and a high level as growth slowed and terminated.

![**Hormone content of CF and YF**. **(A)** IAA content. **(B)** GA content. **(C)** ABA content. **(D)** ZR content. Approximately 0.5 g leaves near shoot tips were used for plant hormone IAA, GA, ZR, and ABA measurements. ^\*^Indicates *P* \< 0.05, Student\'s *t*-test; Error bars indicate SE.](fpls-08-00441-g0002){#F2}

Small RNA sequencing profiles in CF and YF
------------------------------------------

Two cDNA libraries of small RNAs from CF and YF were sequenced in order to identify miRNAs involved in apple shoot development. The sequencing produced a total of 13,264,874 raw reads from CF and 19,773,007 from YF (Table [S1](#SM3){ref-type="supplementary-material"}). After removal of the adaptor sequences, filtering out low-quality tags, and omitting contamination resulting from adaptor--adaptor ligations, 13,083,017 (98.95% of the total) CF and 19,580,358 (99.41%) YF clean reads remained, comprising 5,872,194 and 7,680,257 CF and YF unique sequences, respectively (Table [S2](#SM4){ref-type="supplementary-material"}). The unique sequences were mapped to the apple genome assembly using SOAP, resulting in 3,674,249 (62.57%) and 4,473,261 (58.24%) genome-matched reads for CF and YF, respectively. A total of 143,629 (2.44%) and 278,103 (2.54%) exon RNAs (sense and antisense), 267,025 (5.08%) and 321,431(4.18%) intron RNAs (sense and antisense), 130,796 (2.23%) and 204,833 (2.67%) rRNAs, 1,973,617 (33.61%) and 2,370,059 (30.86%) repeat regions, 4733 (0.08%) and 6054 (0.08%) snRNAs, 1,238 (0.02%) and 1,451 (0.02%) snoRNAs, 11,364 (0.19%), and 15,596 (0.20%) tRNAs, were removed from the CF and YF reads, respectively, This left 3,338,736 (56.86%) and 4,564,590 (59.43%) unannotated CF and YF RNAs, respectively, and a total of 1,056 (0.02%) and 1,149 (0.01%) miRNA reads for CF and YF, respectively. These were utilized as miRNA candidates in subsequent analyses. The read lengths in the two small RNA libraries were assessed (Figure [3A](#F3){ref-type="fig"}).The lengths ranged of the designated small RNAs ranged from 21 to 24 nt and accounted for more than 90% (approximately 92.9% and 94.6% of the CF and YF sequences, respectively) of all the clean reads in each library. The 24 nt small RNA was the most abundant small RNA length (about 50%). Similar results were reported in apple leaves, flowers, fruit, and roots (Xia et al., [@B49]), peach (*Prunus persica*) (Zhu et al., [@B56]), pear (*Pyrus bretschneideri*) (Wu et al., [@B47]), tomato (*Lycopersicon esculentum*) (Gao et al., [@B16]), and chickpea (Jain et al., [@B20]). The next most abundant small RNAs were 21 nt \> 22 nt \> 23 nt. There was a greater number of 23 nt and 24 nt small RNA in CF than in YF. The number of 21 and 22 nt small RNA were greater in YF than in CF.

![**Summary of miRNA in CF and YF shoot tips. (A)** The length distribution of small RNAs. **(B)** Venn diagrams of known and novel miRNAs in CF and YF shoot tips. **(C)** Known miRNA family members in CF and YF shoot tips. **(D)** miRNA reads counts frequency in CF and YF shoot tips. **(E)** Reads numbers of high expression miRNAs in shoot tips.](fpls-08-00441-g0003){#F3}

The clean reads in each library were queried against the *Malus domestica* microRNA database in miRBase in order to identify the known miRNAs that were present in CF and YF apple shoot tips. Collectively, one million reads from the two libraries were perfectly matched to the *Malus domestica* microRNA database. A total of 202 unique sRNAs sequences were assigned to 41 microRNA families (Table [S3](#SM5){ref-type="supplementary-material"}, Figure [3B](#F3){ref-type="fig"}).

A comparison of family members revealed that the number of miRNA members varied among the different miRNA families (Figure [3C](#F3){ref-type="fig"}). The top five miRNA families, mdm-miR156, mdm-miR172, mdm-miR171, mdm-miR167, and mdm-miR399, had more than 10 members. For example, the mdm-miR156 family had 31 members. mdm-miR1511, mdm-miR391, mdm-miR7125, mdm-miR7126, mdm-miR827, and mdm-miR858 only had one member. miRNA156 is conserved in embryophytes (Zhang et al., [@B52]; Taylor et al., [@B44]) and represents the largest microRNA family in pear (Wu et al., [@B47]), which like apple, is a member of the Rosaceae. The differences in the number of members in the different microRNA families may be due to the different evolutionary rates in the microRNA families and to genome duplication events. Two known microRNAs families, mdm-miR7123, and mdm-miR7128, were not found to be present in the libraries (Figure [3C](#F3){ref-type="fig"}), therefore, these microRNAs may not be expressed in apple shoot tips. Statistical analysis of the read counts for the known miRNA families indicated significant differences in the level of expression among the different miRNAs (Table [S3](#SM5){ref-type="supplementary-material"}). Read counts of some miRNAs in a family were nearly the same, but some were obviously different. For example, all of the mdm-miR395 family members had the same number of counts. In contrast, mdm-miR172a, mdm-miR172o, and mdm-miR172g-h, members of the mdm-miR172 family (15 members), had a high read count, while mdm-miR172 a-c, mdm-miR172i-k, and mdm-miR172 m-o had a moderate read count, and mdm-miR172l had a low count. Perhaps some of the microRNA clustered in the same area of the genome, and thus had the same *cis*-regulation elements.

The read counts of about 30% of the known miRNAs were greater than 1,000 (Figure [3D](#F3){ref-type="fig"}). Another 30% of the known miRNA had read counts between 100 and 1,000. Due to high level of expression of miRNA in the apple shoot tip tissue, these miRNAs could be accurately identified. Approximately 20% of the known miRNA had read counts between 0 and 20.

Among the miRNA in YF and CF shoot tips, mdm-miRNA166 families exhibited the highest level of expression, with approximately 10,000 standardized reads (Figure [3E](#F3){ref-type="fig"}). This was followed by mdm-miR482a-5p, which had about 4000 standardized reads. The juvenile to adult phase transition related microRNAs, mdm-miR156 and mdm-miR172, and the flowering related, mdm-miR535, mdm-miR168, and mdm-miR167, also showed high expression levels in apple shoot tips.

After the identification of the known miRNAs, the unannotated tags were analyzed using MIREAP software in order to identify novel miRNAs based on the characteristics of the secondary hairpin structure of miRNA precursors. Using the hairpin structures of the precursors, 498 novel miRNAs were identified. The 23 nt length novel miRNAs represented an overwhelming amount 76.8% of the 306 total novel miRNAs identified (Table [S4](#SM6){ref-type="supplementary-material"}).

The novel miRNA was used a query to blast the miRBASE 18.0. Results indicated that 11 of the 498 novel miRNAs possessed a high significant similarity to known miRNAs from rice, wheat, and other plant species (Figure [4](#F4){ref-type="fig"}). Some varied only in nucleotide length, which may be due to differential cleavage sites in the pre-miRNA. These miRNAs represent new members of conserved miRNA families, and as a result, were designated as novel miRNA isoforms. The novel miRNAs would be species-specific *Malus domestica* miRNA.

![**Clustering of conserved and novel miRNAs into families**.](fpls-08-00441-g0004){#F4}

Lower negative minimal folding free energy (MFE) value for RNA secondary structure, indicates greater stability (Bonnet et al., [@B4]). The average negative MFE was −51.03 kcal/mol (Table [S4](#SM6){ref-type="supplementary-material"}). This MFE value is similar to the data for *Arabidopsis thaliana* miRNA precursors (−57 kcal/mol) (Debat and Ducasse, [@B10]), chickpea (−57.58 kcal/mol) (Jain et al., [@B20]), maize (−61.15 kcal/mol) (Li et al., [@B28]), and pear (−51.48 kcal/mol) (Wu et al., [@B47]).

The GC content of miRNA has been shown to be related to biological function (Mishra et al., [@B33]). The GC content of 90% of the novel miRNA ranged between 30 and 70% (Table [S4](#SM6){ref-type="supplementary-material"}) with an average value of 42%. This average GC is similar to *Arabidopsis* (44%), pear (45%), and chickpea (44%), but less than grape (50%) and the GC content of the known miRNA of apple (50%).

The U residue is the most prevalent nucleotide at the first 5′ nucleotide site of miRNA, especially 21 nt miRNA (Chen, [@B8]). About 46% of the 5′ end nucleotides of the 21 nt novel miRNAs were U (Figure [S2](#SM2){ref-type="supplementary-material"}).

Differentially expressed miRNAs
-------------------------------

The abundances of miRNA reads in the CF and YF libraries were compared in order to identify miRNAs involved in shoot development and to determine their expression pattern in the two different genotypes with contrasting phenotypes. A total of 42 miRNAs, belonging to 12 known miRNA families, were identified whose expression differed significantly between the CF and YF shoot tips (Figure [5A](#F5){ref-type="fig"}). Among these, only mdm-miR5225c and mdm-miR7125 were upregulated in YF. In contrast, five members of mdm-miR164, three members of mdm-miR171, six members of mdm-miR172, three members of mdm-miR393, nine members of mdm-miR395, two members of mdm-miR396, six members of mdm-miR399, two members of mdm-miR5225, two members of mdm-miR7124, and mdm-miR858 were all downregulated in YF shoot tips.

![**Expression of miRNA in CF and YF shoot tips. (A)** Differential expression of known miRNAs in CF and YF shoot tips. **(B)** Differential expression of novel miRNAs in CF and YF shoot tips.](fpls-08-00441-g0005){#F5}

Among of the 498 novel miRNAs, the expression of 93 differed significantly between CF and YF. A total of 34 upregulated and 59 were downregulated in YF (Figure [5B](#F5){ref-type="fig"}). A total of 49 novel miRNAs were expressed only in CF while 28 novel miRNAs were expressed only in YF (Table [S4](#SM6){ref-type="supplementary-material"}).

Target prediction of miRNAs
---------------------------

Plant miRNAs pair with their complementary target and inhibit translation or degrade the target mRNA. The complementary pairing of the miRNA/mRNA duplex provides a useful approach for target prediction. In order to better understand the role of apple miRNAs in shoot development, psRNATarget software was used to predict potential miRNA target genes. Using previously described criteria, 689 potential targets for 168 of the known miRNAs, and 3,663 targets for the 466 novel miRNAs were predicted (Tables [S5](#SM7){ref-type="supplementary-material"}, [S6](#SM8){ref-type="supplementary-material"}). The number of predicted targets for the various miRNAs varied from one to as many as 20, suggesting that these miRNAs may have diverse biological functions. On the other hand, a single gene may also be targeted by several miRNAs. MDP0000237964 encodes a LAC gene that is targeted by mdm-miR397 at two different sites, and two similar CuRO_LCC_plant domains (Figure [6A](#F6){ref-type="fig"}). miRNA828 and miRNA858 target the MYB family at the R3 domian (Xia et al., [@B49]; Figure [6B](#F6){ref-type="fig"}). MDP0000147309 is likely to be targeted by mdm-mi159 and mdm-mi319 (Figure [6C](#F6){ref-type="fig"}).

![**Complementary targeting by miRNAs. (A)** miRNA397a/b targets the MDP0000237946 at two different sites. **(B)** miRNA828 and miRNA858 co-target the MYB conserved sequence. **(C)** miRNA159 and miRNA319 co-target MDP0000147309.](fpls-08-00441-g0006){#F6}

Degradome sequencing was conducted in order to better understand the role of miRNA-target regulation in shoot tips. Approximately 23 million total clean reads were generated from the degradome sequencing. About 49.5% of the unique reads mapped to apple mRNA (Table [S7](#SM9){ref-type="supplementary-material"}). The degradome sequencing results indicated that 246 genes are potentially regulated by 164 miRNAs, including both known and novel miRNAs. The main miRNAs and their target genes verified by degradome sequencing are listed in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}. Two-thirds of the degradome validated known miRNA target genes also identified in the target gene prediction software.

###### 

**Identification potential target genes of known miRNA by the degradome sequencing**.

  **miRNA**     **Target ID**                    **Target function**                                                                       **Homologous At. gene**   **Abbreviation**
  ------------- -------------------------------- ----------------------------------------------------------------------------------------- ------------------------- ----------------------
  mdm-miR156    [MDP0000146640](MDP0000146640)   Squamosa promoter-binding protein-like family protein                                     [AT1G69170](AT1G69170)    
  mdm-miR156    [MDP0000155354](MDP0000155354)   Squamosa promoter binding protein-like 2                                                  [AT5G43270](AT5G43270)    SPL2
  mdm-miR156    [MDP0000249364](MDP0000249364)   Acyl-CoA synthetase 5                                                                     [AT1G62940](AT1G62940)    ACOS5
  mdm-miR156    [MDP0000297978](MDP0000297978)   Squamosa promoter binding protein-like 9                                                  [AT2G42200](AT2G42200)    SPL9
  mdm-miR156    [MDP0000589558](MDP0000589558)   Squamosa promoter-binding protein-like (SBP domain) transcription factor family protein   [AT1G69170](AT1G69170)    
  mdm-miR156    [MDP0000778465](MDP0000778465)   Squamosa promoter-binding protein-like (SBP domain) transcription factor family protein   [AT1G69170](AT1G69170)    
  mdm-miR159    [MDP0000123466](MDP0000123466)   Auxin response factor 2                                                                   [AT5G62000](AT5G62000)    ARF2,
  mdm-miR159    [MDP0000147309](MDP0000147309)   MYB domain protein 65                                                                     [AT3G11440](AT3G11440)    MYB65
  mdm-miR159    [MDP0000237553](MDP0000237553)   TEOSINTE BRANCHED 1, cycloidea and PCF transcription factor 2                             [AT4G18390](AT4G18390)    TCP2
  mdm-miR159    [MDP0000278072](MDP0000278072)   Alpha/beta-Hydrolases superfamily protein                                                 [AT3G23600](AT3G23600)    
  mdm-miR159    [MDP0000287069](MDP0000287069)   TEOSINTE BRANCHED 1, cycloidea and PCF transcription factor 2                             [AT4G18390](AT4G18390)    TCP2
  mdm-miR159    [MDP0000328318](MDP0000328318)   TCP family transcription factor 4                                                         [AT3G15030](AT3G15030)    MEE35, TCP4
  mdm-miR159    [MDP0000442611](MDP0000442611)   TCP family transcription factor 4                                                         [AT3G15030](AT3G15030)    MEE35, TCP4
  mdm-miR159    [MDP0000763497](MDP0000763497)   TEOSINTE BRANCHED 1, cycloidea and PCF transcription factor 2                             [AT4G18390](AT4G18390)    TCP2
  mdm-miR159    [MDP0000916623](MDP0000916623)   TCP family transcription factor 4                                                         [AT3G15030](AT3G15030)    MEE35, TCP4
  mdm-miR159    [MDP0000920127](MDP0000920127)   TEOSINTE BRANCHED 1, cycloidea and PCF transcription factor 2                             [AT4G18390](AT4G18390)    TCP2
  mdm-miR159    [MDP0000927314](MDP0000927314)   TEOSINTE BRANCHED 1, cycloidea and PCF transcription factor 2                             [AT4G18390](AT4G18390)    TCP2
  mdm-miR160    [MDP0000232116](MDP0000232116)   Auxin response factor 17                                                                  [AT1G77850](AT1G77850)    ARF17
  mdm-miR160    [MDP0000256621](MDP0000256621)   Auxin response factor 17                                                                  [AT1G77850](AT1G77850)    ARF17
  mdm-miR160    [MDP0000273491](MDP0000273491)   Co-chaperone GrpE family protein                                                          [AT1G36390](AT1G36390)    
  mdm-miR160    [MDP0000750392](MDP0000750392)   Auxin response factor 16                                                                  [AT4G30080](AT4G30080)    ARF16
  mdm-miR164    [MDP0000121265](MDP0000121265)   NAC domain containing protein 100                                                         [AT5G61430](AT5G61430)    NAC100,
  mdm-miR164    [MDP0000911724](MDP0000911724)   NAC domain containing protein 100                                                         [AT5G61430](AT5G61430)    NAC100
  mdm-miR166    [MDP0000005879](MDP0000005879)   Homeobox gene 8                                                                           [AT4G32880](AT4G32880)    ATHB8,
  mdm-miR166    [MDP0000050082](MDP0000050082)   Homeobox-leucine zipper family protein                                                    [AT2G34710](AT2G34710)    ATHB-1ATHB14, PHB
  mdm-miR166    [MDP0000126553](MDP0000126553)   Homeobox gene 8                                                                           [AT4G32880](AT4G32880)    ATHB8
  mdm-miR166    [MDP0000236500](MDP0000236500)   Homeobox-leucine zipper family protein                                                    [AT5G60690](AT5G60690)    IFL, REV
  mdm-miR166    [MDP0000242861](MDP0000242861)   Homeobox-leucine zipper family protein                                                    [AT5G60690](AT5G60690)    IFL, EV
  mdm-miR166    [MDP0000251484](MDP0000251484)   Homeobox-leucine zipper family protein                                                    [AT1G52150](AT1G52150)    ATHB15, ICU4
  mdm-miR166    [MDP0000313059](MDP0000313059)   Homeobox-leucine zipper family protein                                                    [AT1G52150](AT1G52150)    ATHB15, ICU4
  mdm-miR166    [MDP0000426630](MDP0000426630)   Homeobox-leucine zipper family protein                                                    [AT5G60690](AT5G60690)    IFL, REV
  mdm-miR166    [MDP0000943529](MDP0000943529)   Homeobox-leucine zipper family protein                                                    [AT2G34710](AT2G34710)    ATHB14, PHB
  mdm-miR167    [MDP0000321541](MDP0000321541)   Phosphoglucomutase/phosphomannomutase family protein                                      [AT1G70730](AT1G70730)    
  mdm-miR167    [MDP0000137461](MDP0000137461)   Phosphoglucomutase/phosphomannomutase family protein                                      [AT5G37020](AT5G37020)    ARF8
  mdm-miR167    [MDP0000153538](MDP0000153538)   Auxin response factor 6                                                                   [AT1G30330](AT1G30330)    ARF6
  mdm-miR167    [MDP0000232417](MDP0000232417)   Auxin response factor 8                                                                   [AT5G37020](AT5G37020)    ARF8
  mdm-miR167    [MDP0000268306](MDP0000268306)   Auxin response factor 19                                                                  [AT1G19220](AT1G19220)    ARF19
  mdm-miR167    [MDP0000319957](MDP0000319957)   Auxin response factor 6                                                                   [AT1G30330](AT1G30330)    ARF6
  mdm-miR167    [MDP0000550049](MDP0000550049)   Auxin response factor 6                                                                   [AT1G30330](AT1G30330)    ARF6
  mdm-miR168    [MDP0000069525](MDP0000069525)   Stabilizer of iron transporter SufD / Polynucleotidyl transferase                         [AT1G48410](AT1G48410)    AGO1
  mdm-miR168    [MDP0000305971](MDP0000305971)   Stabilizer of iron transporter SufD / Polynucleotidyl transferase                         [AT1G48410](AT1G48410)    AGO1
  mdm-miR168    [MDP0000352771](MDP0000352771)                                                                                                                       
  mdm-miR169    [MDP0000146933](MDP0000146933)   Nuclear factor Y, subunit A9                                                              [AT3G20910](AT3G20910)    NF-YA9
  mdm-miR169    [MDP0000164531](MDP0000164531)   Nuclear factor Y, subunit A7                                                              [AT1G30500](AT1G30500)    NF-YA7
  mdm-miR169    [MDP0000183865](MDP0000183865)   Nuclear factor Y, subunit A7                                                              [AT1G30500](AT1G30500)    NF-YA7
  mdm-miR169    [MDP0000279028](MDP0000279028)   Nuclear factor Y, subunit A7                                                              [AT1G30500](AT1G30500)    NF-YA7
  mdm-miR169    [MDP0000296077](MDP0000296077)   Nuclear factor Y, subunit A1                                                              [AT5G12840](AT5G12840)    NF-YA1
  mdm-miR171    [MDP0000151144](MDP0000151144)   GRAS family transcription factor                                                          [AT4G00150](AT4G00150)    HAM3
  mdm-miR171    [MDP0000274120](MDP0000274120)   GRAS family transcription factor                                                          [AT4G00150](AT4G00150)    HAM3
  mdm-miR171    [MDP0000275704](MDP0000275704)   GRAS family transcription factor                                                          [AT4G00150](AT4G00150)    HAM3
  mdm-miR171    [MDP0000784909](MDP0000784909)   GRAS family transcription factor                                                          [AT2G45160](AT2G45160)    HAM1
  mdm-miR172    [MDP0000137561](MDP0000137561)   Integrase-type DNA-binding superfamily protein                                            [AT4G36920](AT4G36920)    AP2, FL1
  mdm-miR172    [MDP0000181606](MDP0000181606)   Related to AP2.7                                                                          [AT2G28550](AT2G28550)    RAP2.7, TOE1
  mdm-miR172    [MDP0000200319](MDP0000200319)   Related to AP2.7                                                                          [AT2G28550](AT2G28550)    RAP2.7, TOE1
  mdm-miR172    [MDP0000204900](MDP0000204900)   Integrase-type DNA-binding superfamily protein                                            [AT4G36920](AT4G36920)    AP2, FL1, FLO2
  mdm-miR172    [MDP0000281079](MDP0000281079)   Related to AP2.7                                                                          [AT2G28550](AT2G28550)    RAP2.7, TOE1
  mdm-miR172    [MDP0000285955](MDP0000285955)   Related to AP2.7                                                                          [AT2G28550](AT2G28550)    RAP2.7, TOE1
  mdm-miR172    [MDP0000296716](MDP0000296716)   Related to AP2.7                                                                          [AT2G28550](AT2G28550)    RAP2.7, TOE1
  mdm-miR2118   [MDP0000221561](MDP0000221561)   NADP-malic enzyme 3                                                                       [AT5G25880](AT5G25880)    ATNADP-ME3, NADP-ME3
  mdm-miR319    [MDP0000147309](MDP0000147309)   MYB domain protein 65                                                                     [AT3G11440](AT3G11440)    MYB65
  mdm-miR319    [MDP0000328318](MDP0000328318)   TCP family transcription factor 4                                                         [AT3G15030](AT3G15030)    MEE35, TCP4
  mdm-miR319    [MDP0000442611](MDP0000442611)   TCP family transcription factor 4                                                         [AT3G15030](AT3G15030)    MEE35, TCP4
  mdm-miR319    [MDP0000916623](MDP0000916623)   TCP family transcription factor 4                                                         [AT3G15030](AT3G15030)    MEE35, TCP4
  mdm-miR390    [MDP0000353698](MDP0000353698)                                                                                                                       
  mdm-miR393    [MDP0000125975](MDP0000125975)   F-box/RNI-like superfamily protein                                                        [AT3G62980](AT3G62980)    TIR1
  mdm-miR393    [MDP0000203334](MDP0000203334)   Auxin signaling F-box 2                                                                   [AT3G26810](AT3G26810)    AFB2
  mdm-miR393    [MDP0000268652](MDP0000268652)   Auxin signaling F-box 3                                                                   [AT1G12820](AT1G12820)    AFB3
  mdm-miR393    [MDP0000469943](MDP0000469943)   Auxin signaling F-box 2                                                                   [AT3G26810](AT3G26810)    AFB2
  mdm-miR393    [MDP0000498419](MDP0000498419)   F-box/RNI-like superfamily protein                                                        [AT3G62980](AT3G62980)    TIR1
  mdm-miR394    [MDP0000576390](MDP0000576390)   Geranylgeranyl pyrophosphate synthase 1                                                   [AT4G36810](AT4G36810)    GGPS1
  mdm-miR394    [MDP0000668869](MDP0000668869)   Geranylgeranyl pyrophosphate synthase 1                                                   [AT4G36810](AT4G36810)    GGPS1
  mdm-miR395    [MDP0000121656](MDP0000121656)   ATP sulfurylase 1                                                                         [AT3G22890](AT3G22890)    APS1
  mdm-miR395    [MDP0000263161](MDP0000263161)   ATP sulfurylase 1                                                                         [AT3G22890](AT3G22890)    APS1
  mdm-miR482    [MDP0000130212](MDP0000130212)   Chaperone DnaJ-domain superfamily protein                                                 [AT1G80920](AT1G80920)    J8
  mdm-miR482    [MDP0000160232](MDP0000160232)   NB-ARC domain-containing disease resistance protein                                       [AT3G14470](AT3G14470)    
  mdm-miR482    [MDP0000194077](MDP0000194077)   Disease resistance protein (TIR-NBS-LRR class), putative                                  [AT5G17680](AT5G17680)    
  mdm-miR482    [MDP0000210772](MDP0000210772)   Disease resistance protein (TIR-NBS-LRR class) family                                     [AT4G12010](AT4G12010)    
  mdm-miR482    [MDP0000222555](MDP0000222555)   Chaperone DnaJ-domain superfamily protein                                                 [AT1G80920](AT1G80920)    J8
  mdm-miR482    [MDP0000287865](MDP0000287865)   Disease resistance protein (TIR-NBS-LRR class) family                                     [AT5G36930](AT5G36930)    
  mdm-miR482    [MDP0000304601](MDP0000304601)   NB-ARC domain-containing disease resistance protein                                       [AT3G14470](AT3G14470)    
  mdm-miR482    [MDP0000311052](MDP0000311052)   Disease resistance protein (TIR-NBS-LRR class) family                                     [AT5G36930](AT5G36930)    
  mdm-miR482    [MDP0000367358](MDP0000367358)                                                                                                                       
  mdm-miR482    [MDP0000810351](MDP0000810351)   NB-ARC domain-containing disease resistance protein                                       [AT3G14470](AT3G14470)    
  mdm-miR482    [MDP0000818967](MDP0000818967)   Nuclear factor Y, subunit B3                                                              [AT4G14540](AT4G14540)    NF-YB3
  mdm-miR482    [MDP0000854581](MDP0000854581)                                                                                                                       
  mdm-miR482    [MDP0000196862](MDP0000196862)   NSP-interacting kinase 3                                                                  [AT1G60800](AT1G60800)    NIK3
  mdm-miR482    [MDP0000252094](MDP0000252094)   NSP-interacting kinase 3                                                                  [AT1G60800](AT1G60800)    NIK3
  mdm-miR7122   [MDP0000296050](MDP0000296050)   Polyol/monosaccharide transporter 5                                                       [AT3G18830](AT3G18830)    ATPLT5
  mdm-miR7122   [MDP0000755167](MDP0000755167)   Polyol/monosaccharide transporter 5                                                       [AT3G18830](AT3G18830)    ATPLT5
  mdm-miR7125   [MDP0000273257](MDP0000273257)   Zinc transporter 1 precursor                                                              [AT3G12750](AT3G12750)    ZIP1
  mdm-miR828    [MDP0000124555](MDP0000124555)   MYB domain protein 66                                                                     [AT5G14750](AT5G14750)    MYB66
  mdm-miR828    [MDP0000133817](MDP0000133817)   MYB domain protein 5                                                                      [AT3G13540](AT3G13540)    MYB5
  mdm-miR828    [MDP0000167314](MDP0000167314)   MYB domain protein 82                                                                     [AT5G52600](AT5G52600)    MYB82
  mdm-miR828    [MDP0000226215](MDP0000226215)   MYB domain protein 5                                                                      [AT3G13540](AT3G13540)    MYB5
  mdm-miR828    [MDP0000253904](MDP0000253904)   MYB domain protein 5                                                                      [AT3G13540](AT3G13540)    MYB5
  mdm-miR828    [MDP0000261265](MDP0000261265)   MYB domain protein 5                                                                      [AT3G13540](AT3G13540)    MYB5
  mdm-miR828    [MDP0000264051](MDP0000264051)   MYB domain protein 82                                                                     [AT5G52600](AT5G52600)    MYB82
  mdm-miR828    [MDP0000578193](MDP0000578193)   MYB domain protein 66                                                                     [AT5G14750](AT5G14750)    MYB66, WER, WER1
  mdm-miR828    [MDP0000642761](MDP0000642761)   MYB domain protein 66                                                                     [AT5G14750](AT5G14750)    MYB66, WER, WER1
  mdm-miR828    [MDP0000650225](MDP0000650225)   MYB domain protein 66                                                                     [AT5G14750](AT5G14750)    MYB66, WER, WER1
  mdm-miR828    [MDP0000931057](MDP0000931057)   High response to osmotic stress 10                                                        [AT1G35515](AT1G35515)    HOS10, MYB8
  mdm-miR858    [MDP0000031172](MDP0000031172)   MYB domain protein 4                                                                      [AT4G38620](AT4G38620)    MYB4
  mdm-miR858    [MDP0000124555](MDP0000124555)   MYB domain protein 66                                                                     [AT5G14750](AT5G14750)    MYB66, WER, WER1
  mdm-miR858    [MDP0000133817](MDP0000133817)   MYB domain protein 5                                                                      [AT3G13540](AT3G13540)    MYB5
  mdm-miR858    [MDP0000140609](MDP0000140609)   MYB domain protein 12                                                                     [AT2G47460](AT2G47460)    MYB12, PFG1
  mdm-miR858    [MDP0000143276](MDP0000143276)   MYB domain protein 5                                                                      [AT3G13540](AT3G13540)    MYB5
  mdm-miR858    [MDP0000184538](MDP0000184538)   MYB domain protein 3                                                                      [AT1G22640](AT1G22640)    MYB3
  mdm-miR858    [MDP0000210851](MDP0000210851)   MYB domain protein 7                                                                      [AT2G16720](AT2G16720)    MYB7
  mdm-miR858    [MDP0000226215](MDP0000226215)   MYB domain protein 5                                                                      [AT3G13540](AT3G13540)    ATMYB5, MYB5
  mdm-miR858    [MDP0000253904](MDP0000253904)   MYB domain protein 5                                                                      [AT3G13540](AT3G13540)    MYB5
  mdm-miR858    [MDP0000318013](MDP0000318013)   Duplicated homeodomain-like superfamily protein                                           [AT5G35550](AT5G35550)    MYB123, TT2
  mdm-miR858    [MDP0000437717](MDP0000437717)   Duplicated homeodomain-like superfamily protein                                           [AT5G35550](AT5G35550)    MYB123, TT2
  mdm-miR858    [MDP0000887107](MDP0000887107)   MYB domain protein 12                                                                     [AT2G47460](AT2G47460)    MYB12, PFG1
  mdm-miR858    [MDP0000931057](MDP0000931057)   High response to osmotic stress 10                                                        [AT1G35515](AT1G35515)    HOS10, MYB8

###### 

**Identification target of novel miRNA by the degradome sequencing**.

  **miRNA**           **Target ID**                    **Target function**                                                                       **Homologous At. gene**   **Abbreviation**
  ------------------- -------------------------------- ----------------------------------------------------------------------------------------- ------------------------- ------------------
  novel_mir_100       [MDP0000360515](MDP0000360515)   ATP synthase alpha/beta family protein                                                    [AT5G08680](AT5G08680)    
  novel_mir_123       [MDP0000253809](MDP0000253809)   Annexin 2                                                                                 [AT5G65020](AT5G65020)    ANNAT2
  novel_mir_124       [MDP0000187925](MDP0000187925)   UDP-glucose pyrophosphorylase 2                                                           [AT5G17310](AT5G17310)    ATUGP2, UGP2
  novel_mir_144       [MDP0000136541](MDP0000136541)   MYB domain protein 105                                                                    [AT1G69560](AT1G69560)    LOF2, MYB105
  novel_mir_144       [MDP0000146675](MDP0000146675)   MYB domain protein 105                                                                    [AT1G69560](AT1G69560)    LOF2, MYB105
  novel_mir_144       [MDP0000330904](MDP0000330904)                                                                                                                       
  novel_mir_176       [MDP0000368249](MDP0000368249)                                                                                                                       
  mdm-novel_miR166a   [MDP0000005879](MDP0000005879)   Homeobox gene 8                                                                           [AT4G32880](AT4G32880)    ATHB8
  mdm-novel_miR166a   [MDP0000050082](MDP0000050082)   Homeobox-leucine zipper family protein / lipid-binding START domain-containing protein    [AT2G34710](AT2G34710)    ATHB14, PHB
  mdm-novel_miR166a   [MDP0000126553](MDP0000126553)   Homeobox gene 8                                                                           [AT4G32880](AT4G32880)    ATHB8
  mdm-novel_miR166a   [MDP0000236500](MDP0000236500)   Homeobox-leucine zipper family protein / lipid-binding START domain-containing protein    [AT5G60690](AT5G60690)    IFL, REV
  mdm-novel_miR166a   [MDP0000242861](MDP0000242861)   Homeobox-leucine zipper family protein / lipid-binding START domain-containing protein    [AT5G60690](AT5G60690)    IFL, REV
  mdm-novel_miR166a   [MDP0000251484](MDP0000251484)   Homeobox-leucine zipper family protein / lipid-binding START domain-containing protein    [AT1G52150](AT1G52150)    ATHB15, ICU4
  mdm-novel_miR166a   [MDP0000313059](MDP0000313059)   Homeobox-leucine zipper family protein / lipid-binding START domain-containing protein    [AT1G52150](AT1G52150)    ATHB15, ICU4
  mdm-novel_miR166a   [MDP0000426630](MDP0000426630)   Homeobox-leucine zipper family protein / lipid-binding START domain-containing protein    [AT5G60690](AT5G60690)    IFL, REV
  mdm-novel_miR166a   [MDP0000943529](MDP0000943529)   Homeobox-leucine zipper family protein / lipid-binding START domain-containing protein    [AT2G34710](AT2G34710)    ATHB14, PHB
  novel_mir_203       [MDP0000161842](MDP0000161842)   Ribosomal protein L4/L1 family                                                            [AT3G09630](AT3G09630)    
  novel_mir_203       [MDP0000680417](MDP0000680417)   Ribosomal protein L4/L1 family                                                            [AT3G09630](AT3G09630)    
  novel_mir_218       [MDP0000665406](MDP0000665406)   HAESA-like 1                                                                              [AT1G28440](AT1G28440)    HSL1
  mdm-novel_miR169a   [MDP0000146933](MDP0000146933)   Nuclear factor Y, subunit A9                                                              [AT3G20910](AT3G20910)    NF-YA9
  mdm-novel_miR169a   [MDP0000164531](MDP0000164531)   Nuclear factor Y, subunit A7                                                              [AT1G30500](AT1G30500)    NF-YA7
  mdm-novel_miR169a   [MDP0000183865](MDP0000183865)   Nuclear factor Y, subunit A7                                                              [AT1G30500](AT1G30500)    NF-YA7
  mdm-novel_miR169a   [MDP0000250518](MDP0000250518)   Voltage dependent anion channel 1                                                         [AT3G01280](AT3G01280)    VDAC1
  mdm-novel_miR169a   [MDP0000279028](MDP0000279028)   Nuclear factor Y, subunit A7                                                              [AT1G30500](AT1G30500)    NF-YA7
  mdm-novel_miR169a   [MDP0000296077](MDP0000296077)   Nuclear factor Y, subunit A1                                                              [AT5G12840](AT5G12840)    NF-YA1
  novel_mir_237       [MDP0000095336](MDP0000095336)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_237       [MDP0000149531](MDP0000149531)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_237       [MDP0000210355](MDP0000210355)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_237       [MDP0000645731](MDP0000645731)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_237       [MDP0000751972](MDP0000751972)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_249       [MDP0000385086](MDP0000385086)   Protein of unknown function (DUF1685)                                                     [AT4G33985](AT4G33985)    
  novel_mir_249       [MDP0000434028](MDP0000434028)   Protein phosphatase 2A subunit A2                                                         [AT3G25800](AT3G25800)    PP2AA2
  novel_mir_249       [MDP0000509949](MDP0000509949)   Peroxidase superfamily protein                                                            [AT1G05260](AT1G05260)    RCI3
  novel_mir_249       [MDP0000511597](MDP0000511597)                                                                                                                       
  novel_mir_249       [MDP0000540293](MDP0000540293)   Protein phosphatase 2A subunit A2                                                         [AT3G25800](AT3G25800)    PP2AA2
  novel_mir_249       [MDP0000541775](MDP0000541775)   Uncharacterised protein family (UPF0497)                                                  [AT3G23200](AT3G23200)    
  novel_mir_249       [MDP0000651056](MDP0000651056)                                                                                             [AT5G05800](AT5G05800)    
  novel_mir_249       [MDP0000674456](MDP0000674456)                                                                                                                       
  novel_mir_249       [MDP0000690147](MDP0000690147)   ARM repeat superfamily protein                                                            [AT4G16490](AT4G16490)    
  novel_mir_249       [MDP0000701629](MDP0000701629)                                                                                                                       
  novel_mir_263       [MDP0000165935](MDP0000165935)   Nucleotide/sugar transporter family protein                                               [AT5G17630](AT5G17630)    
  novel_mir_266       [MDP0000368249](MDP0000368249)                                                                                                                       
  novel_mir_292       [MDP0000530198](MDP0000530198)   EXORDIUM like 3                                                                           [AT5G51550](AT5G51550)    EXL3
  novel_mir_292       [MDP0000778016](MDP0000778016)   EXORDIUM like 3                                                                           [AT5G51550](AT5G51550)    EXL3
  mdm-novel_miR159a   [MDP0000147309](MDP0000147309)   MYB domain protein 65                                                                     [AT3G11440](AT3G11440)    MYB65
  novel_mir_348       [MDP0000297664](MDP0000297664)   Mitochondrial substrate carrier family protein                                            [AT5G19760](AT5G19760)    
  novel_mir_384       [MDP0000125404](MDP0000125404)   Protein of unknown function, DUF538                                                       [AT1G02816](AT1G02816)    
  novel_mir_384       [MDP0000160246](MDP0000160246)   Protein of unknown function, DUF538                                                       [AT1G02816](AT1G02816)    
  novel_mir_384       [MDP0000757026](MDP0000757026)   Protein of unknown function, DUF538                                                       [AT1G02816](AT1G02816)    
  novel_mir_388       [MDP0000751972](MDP0000751972)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_421       [MDP0000751972](MDP0000751972)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_447       [MDP0000095336](MDP0000095336)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_447       [MDP0000149531](MDP0000149531)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_447       [MDP0000210355](MDP0000210355)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_447       [MDP0000645731](MDP0000645731)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_447       [MDP0000751972](MDP0000751972)   Serine protease inhibitor (SERPIN) family protein                                         [AT1G47710](AT1G47710)    
  novel_mir_454       [MDP0000265913](MDP0000265913)   Farnesyl diphosphate synthase 1                                                           [AT5G47770](AT5G47770)    FPS1
  novel_mir_454       [MDP0000299402](MDP0000299402)   Farnesyl diphosphate synthase 1                                                           [AT5G47770](AT5G47770)    FPS1
  novel_mir_493       [MDP0000126528](MDP0000126528)   F-box family protein                                                                      [AT4G24210](AT4G24210)    SLY1
  novel_mir_497       [MDP0000204850](MDP0000204850)   Pentatricopeptide repeat (PPR) superfamily protein                                        [AT3G53700](AT3G53700)    MEE40
  novel_mir_58        [MDP0000240422](MDP0000240422)   Ribosomal protein L10 family protein                                                      [AT2G40010](AT2G40010)    
  novel_mir_58        [MDP0000398869](MDP0000398869)   Ribosomal protein L10 family protein                                                      [AT2G40010](AT2G40010)    
  novel_mir_58        [MDP0000749281](MDP0000749281)   Ribosomal protein L10 family protein                                                      [AT2G40010](AT2G40010)    
  novel_mir_79        [MDP0000243304](MDP0000243304)   NB-ARC domain-containing disease resistance protein                                       [AT3G14470](AT3G14470)    
  novel_mir_80        [MDP0000589558](MDP0000589558)   Squamosa promoter-binding protein-like (SBP domain) transcription factor family protein   [AT1G69170](AT1G69170)    
  novel_mir_86        [MDP0000320808](MDP0000320808)   ENTH/VHS/GAT family protein                                                               [AT1G06210](AT1G06210)    
  novel_mir_93        [MDP0000231391](MDP0000231391)   Leucine-rich repeat protein kinase family protein                                         [AT2G01820](AT2G01820)    
  novel_mir_93        [MDP0000268423](MDP0000268423)   Leucine-rich repeat protein kinase family protein                                         [AT2G01820](AT2G01820)    

GO and KEGG analysis of the degradome-predicted target genes in shoot tips
--------------------------------------------------------------------------

BLASTX querying against the protein database, Gene Ontology (GO), and KEGG pathway analysis were used to annotate the target genes identified in the degradome analysis in order to determine the potential functions of the miRNA target genes. A total of 69 degradome-identified target genes of 21 known miRNA were associated with 238 GO terms (Table [S8](#SM10){ref-type="supplementary-material"}). The first three enrichment GOs were GO:0005634, GO:0003700, and GO:0006351. GO:0005634, involved with the nucleus in the cellular component had 49 associated target genes. GO:0003700 involved in transcription factor activity in the molecular function component had 45 associated target genes. GO:0006351, involved in transcription, DNA-dependent in the biological process component had 41 associated target genes.

KEGG pathway analysis indicated that the target genes were involved in 21 pathways, in which, Transcription factors, ko03000; Metabolic pathways, ko01100, and; Plant hormone signal transduction, ko04075 were significantly enriched (Table [S9](#SM11){ref-type="supplementary-material"}).

Twenty-nine of the degradome identified genes targeted by 15 of the novel miRNAs were assigned to 176 GO terms (Table [S10](#SM12){ref-type="supplementary-material"}). Like the known miRNA, the GO enrichment in novel miRNA were transcription regulation related GO terms: 13 genes in GO:0005634; 9 genes in GO:0006355; 9 genes in GO:0003677, and; 7 genes in GO:0003700. KEGG pathway analysis indicated that the target genes were involved in 35 pathways, in which, Transcription factors, ko03000, and Metabolic pathways: ko01100 were significantly enriched. (Table [S11](#SM13){ref-type="supplementary-material"}).

YF exhibited a shorter duration of shoot elongation (Figure [1B](#F1){ref-type="fig"}). The duration of shoot growth is regulated by the shoot apical meristem (SAM). Based on the GO annotation of the target genes and with the KEGG pathway analysis, the potential targets of miR164, miR166, miR171, miR172, and miR482 are involved in meristem development (Table [3](#T3){ref-type="table"}). In particular, miR164 participates in the formation of meristem-to-organ boundaries in the SAM (Laufs et al., [@B25]). The potential targets of miR166, miR159, and miR156 are involved in meristem phase transition. The potential targets of miR167, miR160, and miR159 play a role in auxin response and the auxin signaling pathway may also participate in SAM development.

###### 

**SAM development relative miRNAs**.

  **Development progress**                      **miRNA**                        **GO term**                                               **GO NO**.   **Target gene**
  --------------------------------------------- -------------------------------- --------------------------------------------------------- ------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Primary shoot apical meristem specification   miR166, miR164                   Primary shoot apical meristem specification               GO:0010072   [MDP0000943529](MDP0000943529), [MDP0000126553](MDP0000126553), [MDP0000911724](MDP0000911724)
  Meristem development                          miR167                           Meristem development                                      GO:0048507   [MDP0000232417](MDP0000232417), [MDP0000550049](MDP0000550049), [MDP0000319957](MDP0000319957)
                                                miR167, miR166                   Meristem initiation                                       GO:0010014   [MDP0000232417](MDP0000232417), [MDP0000319957](MDP0000319957), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000126553](MDP0000126553), [MDP0000251484](MDP0000251484)
                                                miR172, miR167, miR166           Meristem maintenance                                      GO:0010073   [MDP0000200319](MDP0000200319), [MDP0000296716](MDP0000296716), [MDP0000281079](MDP0000281079), [MDP0000204900](MDP0000204900), [MDP0000181606](MDP0000181606), [MDP0000137561](MDP0000137561), [MDP0000232417](MDP0000232417), [MDP0000319957](MDP0000319957), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000251484](MDP0000251484)
                                                miR482, miR166                   Regulation of meristem growth                             GO:0010075   [MDP0000196862](MDP0000196862), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000251484](MDP0000251484)
                                                miR166                           Regulation of cell differentiation                        GO:0045595   [MDP0000126553](MDP0000126553)
  Phase transition of meristem                  miR166, miR159, miR156           Vegetative to reproductive phase transition of meristem   GO:0010228   [MDP0000126553](MDP0000126553), [MDP0000442611](MDP0000442611), [MDP0000916623](MDP0000916623), [MDP0000297978](MDP0000297978)
  Plant hormone related                         miR393                           Auxin binding                                             GO:0010011   [MDP0000268652](MDP0000268652), [MDP0000203334](MDP0000203334), [MDP0000125975](MDP0000125975)
                                                miR393, miR167, miR160, miR159   Auxin mediated signaling pathway                          GO:0009734   [MDP0000268652](MDP0000268652), [MDP0000498419](MDP0000498419), [MDP0000203334](MDP0000203334), [MDP0000125975](MDP0000125975), [MDP0000232417](MDP0000232417), [MDP0000268306](MDP0000268306), [MDP0000550049](MDP0000550049), [MDP0000319957](MDP0000319957), [MDP0000232116](MDP0000232116), [MDP0000123466](MDP0000123466)
                                                miR858, miR159                   Response to abscisic acid stimulus                        GO:0009737   [MDP0000318013](MDP0000318013), [MDP0000123466](MDP0000123466)
                                                miR858, miR393, miR167, miR166   Response to auxin stimulus                                GO:0009733   [MDP0000210851](MDP0000210851), [MDP0000125975](MDP0000125975), [MDP0000232417](MDP0000232417), [MDP0000268306](MDP0000268306), [MDP0000550049](MDP0000550049), [MDP0000319957](MDP0000319957), [MDP0000126553](MDP0000126553)
                                                miR858, miR167                   Response to ethylene stimulus                             GO:0009723   [MDP0000210851](MDP0000210851), [MDP0000268306](MDP0000268306)
                                                miR858, miR393                   Ethylene mediated signaling pathway                       GO:0009873   [MDP0000318013](MDP0000318013), [MDP0000125975](MDP0000125975)
                                                miR167                           Response to brassinosteroid stimulus                      GO:0009741   [MDP0000268306](MDP0000268306)
  Flower ogran development                      miR172, miR167, miR159           Ovule development                                         GO:0048481   [MDP0000200319](MDP0000200319), [MDP0000296716](MDP0000296716), [MDP0000281079](MDP0000281079), [MDP0000204900](MDP0000204900), [MDP0000181606](MDP0000181606), [MDP0000137561](MDP0000137561), [MDP0000232417](MDP0000232417), [MDP0000550049](MDP0000550049), [MDP0000319957](MDP0000319957), [MDP0000442611](MDP0000442611), [MDP0000123466](MDP0000123466), [MDP0000916623](MDP0000916623)
                                                miR166                           Polarity specification of adaxial/abaxial axis            GO:0009944   [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000126553](MDP0000126553), [MDP0000251484](MDP0000251484)
                                                miR169, miR160                   Pollen development                                        GO:0009555   [MDP0000296077](MDP0000296077), [MDP0000232116](MDP0000232116)
                                                miR156                           Pollen exine formation                                    GO:0010584   [MDP0000249364](MDP0000249364)
                                                miR393                           Pollen maturation                                         GO:0010152   [MDP0000268652](MDP0000268652), [MDP0000203334](MDP0000203334), [MDP0000125975](MDP0000125975)
                                                miR159                           Pollen sperm cell differentiation                         GO:0048235   [MDP0000147309](MDP0000147309)
                                                miR2118                          Pollen tube growth                                        GO:0009860   [MDP0000221561](MDP0000221561)
                                                miR167                           Regulation of flower development                          GO:0009909   [MDP0000232417](MDP0000232417), [MDP0000550049](MDP0000550049), [MDP0000319957](MDP0000319957)
                                                miR393                           Stamen development                                        GO:0048443   [MDP0000268652](MDP0000268652), [MDP0000203334](MDP0000203334), [MDP0000125975](MDP0000125975)
                                                miR172, miR167                   Flower development                                        GO:0009908   [MDP0000200319](MDP0000200319), [MDP0000296716](MDP0000296716), [MDP0000281079](MDP0000281079), [MDP0000204900](MDP0000204900), [MDP0000181606](MDP0000181606), [MDP0000137561](MDP0000137561)
                                                miR167, miR166                   Flower morphogenesis                                      GO:0048439   [MDP0000232417](MDP0000232417), [MDP0000550049](MDP0000550049), [MDP0000319957](MDP0000319957), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000251484](MDP0000251484)
                                                miR172, miR166                   Tissue development                                        GO:0009888   [MDP0000200319](MDP0000200319), [MDP0000296716](MDP0000296716), [MDP0000281079](MDP0000281079), [MDP0000204900](MDP0000204900)
  Embryonic development                         miR396                           Embryonic axis specification                              GO:0000578   [MDP0000168690](MDP0000168690)
                                                miR396, miR169                   Embryonic development                                     GO:0009790   [MDP0000168690](MDP0000168690), [MDP0000296077](MDP0000296077)
                                                miR166, miR159                   Embryonic development ending in seed dormancy             GO:0009793   [MDP0000126553](MDP0000126553), [MDP0000442611](MDP0000442611), [MDP0000916623](MDP0000916623)
                                                miR166                           Embryonic pattern specification                           GO:0009880   [MDP0000943529](MDP0000943529), [MDP0000126553](MDP0000126553)
  Formation of organ boundary                   miR164                           Formation of organ boundary                               GO:0010160   [MDP0000911724](MDP0000911724)
                                                miR166                           Polarity specification of adaxial/abaxial axis            GO:0009944   [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000126553](MDP0000126553), [MDP0000251484](MDP0000251484)
                                                miR167, miR166                   Determination of bilateral symmetry                       GO:0009855   [MDP0000232417](MDP0000232417), [MDP0000550049](MDP0000550049), [MDP0000319957](MDP0000319957), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529)
                                                miR166                           Determination of dorsal identity                          GO:0048263   [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000251484](MDP0000251484)

Internode length is determined by cell division and cell elongation. Based on the GO annotation of the target genes and the KEGG pathway analysis, miRNAs related to cell division and cell differentiation were identified (Table [4](#T4){ref-type="table"}). The potential targets of miR159, miR166, miR167, miR171, miR172, miR393, miR858, and miR828 are involved in cell growth. Gibberellin also plays an important role in regulating internode length. The potential targets of miR159 are involved in the gibberellic acid mediated signaling pathway and gibberellin biosynthetic process. While the potential targets of miRNA160 and miRNA167 regulate auxin response to control cell division. Thus, the potential targets of miR167, involved in response to brassinosteroid stimulus and the auxin-mediated signaling pathway, may play a role in internode development. Secondary metabolism affects primary growth by competing for common substrates. The potential targets of miR858, miR828, and miR156 participate in the fatty acid biosynthetic process. Cell walls also affect cell elongation and cell size. The potential targets of miR166 and miR167 are involved in cell wall biogenesis and cell wall organization. Mineral nutrition affects plant physiology and growth and the potential targets of miR169, miR166, miR7125, miR393, and miR395 are involved in mineral element response.

###### 

**Internode growth related miRNAs**.

  **Development progress**              **miRNA**                        **GO term**                                   **GO NO**.                                                       **Target gene**
  ------------------------------------- -------------------------------- --------------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cell growth                           miR167, miR166                   Cell adhesion                                 GO:0007155                                                       [MDP0000268306](MDP0000268306), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000126553](MDP0000126553), [MDP0000251484](MDP0000251484)
                                        miR393                           Cell cycle                                    GO:0007049                                                       [MDP0000125975](MDP0000125975)
                                        miR172, miR171, miR166, miR159   Cell differentiation                          GO:0030154                                                       [MDP0000200319](MDP0000200319), [MDP0000296716](MDP0000296716)
                                        miR171, miR166                   Cell division                                 GO:0051301                                                       [MDP0000275704](MDP0000275704), [MDP0000151144](MDP0000151144), [MDP0000784909](MDP0000784909), [MDP0000126553](MDP0000126553)
                                        miR858, miR828                   Cell fate commitment                          GO:0045165                                                       [MDP0000184538](MDP0000184538), [MDP0000578193](MDP0000578193), [MDP0000261265](MDP0000261265), [MDP0000650225](MDP0000650225), [MDP0000124555](MDP0000124555)
                                        miR858, miR828                   Cell fate specification                       GO:0001708                                                       [MDP0000184538](MDP0000184538), [MDP0000578193](MDP0000578193), [MDP0000931057](MDP0000931057), [MDP0000261265](MDP0000261265), [MDP0000650225](MDP0000650225), [MDP0000124555](MDP0000124555)
                                        miR166                           Cell growth                                   GO:0016049                                                       [MDP0000126553](MDP0000126553)
                                        miR166                           Cell wall biogenesis                          GO:0042546                                                       [MDP0000126553](MDP0000126553)
                                        miR166                           Cell wall macromolecule metabolic process     GO:0044036                                                       [MDP0000126553](MDP0000126553)
                                        miR167, miR166                   Cell wall organization                        GO:0071555                                                       [MDP0000268306](MDP0000268306), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000126553](MDP0000126553), [MDP0000251484](MDP0000251484)
  Xylem development                     miR167, miR166                   Xylem and phloem pattern formation            GO:0010051                                                       [MDP0000232417](MDP0000232417), [MDP0000550049](MDP0000550049), [MDP0000319957](MDP0000319957), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000251484](MDP0000251484)
                                        miR166                           Xylem development                             GO:0010089                                                       [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000126553](MDP0000126553), [MDP0000251484](MDP0000251484)
  Gibberellin                           miR159                           Gibberellic acid mediated signaling pathway   GO:0009740                                                       [MDP0000147309](MDP0000147309)
                                        miR159                           Gibberellin biosynthetic process              GO:0009686                                                       [MDP0000147309](MDP0000147309)
  Fatty acid biosynthetic process       miR858, miR828                   Fatty acid biosynthetic process               GO:0006633                                                       [MDP0000887107](MDP0000887107), [MDP0000437717](MDP0000437717), [MDP0000226215](MDP0000226215), [MDP0000253904](MDP0000253904)
                                        miR156                           Fatty-acyl-CoA biosynthetic process           GO:0046949                                                       [MDP0000249364](MDP0000249364)
  Flavonoid biosynthetic process        miR858, miR828                   Flavonoid biosynthetic process                GO:0009813                                                       [MDP0000210851](MDP0000210851), [MDP0000887107](MDP0000887107), [MDP0000437717](MDP0000437717), [MDP0000251486](MDP0000251486)
  Ethylene mediated signaling pathway   miR393                           Ethylene mediated signaling pathway           GO:0009873                                                       [MDP0000125975](MDP0000125975)
                                        miR858, miR393                   Ethylene mediated signaling pathway           GO:0009873                                                       [MDP0000318013](MDP0000318013), [MDP0000125975](MDP0000125975)
  Cell wall development                 miR166                           Cell wall biogenesis                          GO:0042546                                                       [MDP0000126553](MDP0000126553)
                                        miR166                           Cell wall macromolecule metabolic process     GO:0044036                                                       [MDP0000126553](MDP0000126553)
                                        miR167, miR166                   Cell wall organization                        GO:0071555                                                       [MDP0000268306](MDP0000268306), [MDP0000313059](MDP0000313059), [MDP0000005879](MDP0000005879), [MDP0000943529](MDP0000943529), [MDP0000251487](MDP0000251487)
  Mineral nutrition                     miR7125                          Cellular response to iron ion starvation      GO:0010106                                                       [MDP0000273257](MDP0000273257)
                                        miR393                           Cellular response to nitrate                  GO:0071249                                                       [MDP0000268652](MDP0000268652), [MDP0000203334](MDP0000203334)
                                        miR166                           Cellular response to nitrogen starvation      GO:0006995                                                       [MDP0000005879](MDP0000005879), [MDP0000251484](MDP0000251484), [MDP0000313059](MDP0000313059)
                                        miR393, miR169                   Cellular response to phosphate starvation     GO:0016036                                                       [MDP0000125975](MDP0000125975), [MDP0000164531](MDP0000164531)
                                        miR395                           Sulfate accumulation and allocation           [MDP0000263161](MDP0000263161), [MDP0000121656](MDP0000121656)   
  Auxin binding                         miR393                           Auxin binding                                 GO:0010011                                                       [MDP0000268652](MDP0000268652), [MDP0000203334](MDP0000203334), [MDP0000125975](MDP0000125975)
                                        miR393, miR167, miR160, miR159   Auxin mediated signaling pathway              GO:0009734                                                       [MDP0000268652](MDP0000268652), [MDP0000498419](MDP0000498419), [MDP0000203334](MDP0000203334), [MDP0000125975](MDP0000125975), [MDP0000232417](MDP0000232417), [MDP0000268306](MDP0000268306), [MDP0000251490](MDP0000251490)

RT-qPCR of differentially expressed miRNAs and their targets involved in SAM development
----------------------------------------------------------------------------------------

The miRNAs and their targets putatively involved in SAM development that were differentially expressed in YF vs. CF are illustrated in Figure [7](#F7){ref-type="fig"}. The expression analysis of miRNAs and their associated target genes revealed inversed expression patterns. The expression of miRNA164 decreased from 45 to 145 DABB in both YF and CF while expression of the potential target gene, *MdNAC*, increased from 45 to 55 DABB, decreased from 85 to 105 DABB, and then increased rapidly after 125 DABB. The expression of miRNA164 in YF was significantly lower than in CF at 45, 65, and 85 DABB. The expression of miRNA166 in CF and YF peaked at 105 DABB. The expression of miRNA166 in YF was significantly higher than in CF at 45, 105, and 125 DABB. The expression of miRNA171 in CF and YF increased from 45 to 65, decreased from 85 to 125, and then increased to a high level at 145 DABB. The potential target of miRNA171, *MdHAM*, fluctuated in its expression level from 45 to 105 DABB, and was then downregulated after 125 DABB. The expression of miRNA171 in YF was significantly lower than CF from 65 to 145 DABB.

![**Differentially expressed miRNAs and their targets involved in SAM development between CF and YF**. ^\*^Indicates *P* \< 0.05, Student\'s *t*-test; Error bars indicate SE.](fpls-08-00441-g0007){#F7}

RT-qPCR of differentially expressed miRNAs and their targets involved in internode elongation
---------------------------------------------------------------------------------------------

MiRNAs and their targets, which are putatively involved in internode elongation, that were differentially expressed in YF vs. CF are shown in Figure [8](#F8){ref-type="fig"}. The expression of miRNA159 in YF was significantly lower at 65, 85, and 125 DABB than it was in CF. The potential target, *MdMYB65*, was downregulated from 45 to 145 DABB. The highest expression level of miRNA167 in both CF and YF was observed during the slow growth period at 80 DABB. The potential target, *MdARF6*, was downregulated from 45 to 125 DABB, and upregulated at 145 DABB. The expression of miRNA167 in YF was significantly higher than in CF at 65, 85, and 105 DABB. The expression of miRNA396 in YF peaked at 105 DABB. The expression of miRNA396 in YF was significantly higher than in CF at 105, 125, and 145 DABB. The miRNA396 potential target gene, *MdGRF*, exhibited a high level during the later growth stage. The expression of miRNA159, miRNA167, and miRNA396 in YF and CF shoot tips exhibited their highest level of expression during the period of slow shoot growth. These data suggest that these miRNAs inhibited cell division in developing shoots.

![**Differentially expressed miRNAs and their targets involved in internode elongation between CF and YF**. ^\*^Indicates *P* \< 0.05, Student\'s *t*-test; Error bars indicate SE.](fpls-08-00441-g0008){#F8}

Expression of cell cycle- and cell elongation-related genes
-----------------------------------------------------------

A strong correlation has been observed between final internode length and cell number (Brown and Sommer, [@B5]). Therefore, the expression of cell cycle and cell elongation related genes were examined (Figure [9](#F9){ref-type="fig"}). The expression of the cell cycle related genes, *MdCYCD, MdCYCB1.2, MdCYCD1.3*, and *MdRBR1* exhibited high levels of transcript abundance during the period of rapid growth after bud break, and were downregulated during the period of slow growth, followed by a slight upregulation at the later stages of sampling. *MdCYCD* expression in YF was significantly lower than in CF from 45 to 125 DABB. Expression levels of *MdCYCB1;2, MdCYCD1;3*, and *MdRBR1* genes in YF were significantly lower than in CF during the period of rapid growth just after bud break. The cell elongation genes, *MdTCH4* and *MdXTH23*, exhibited high expression levels during the period of slow growth and in the autumn. *MdTCH2* and *MdXTH23* expression in YF exhibited a lower expression level than in CF during these periods.

![**Expression of cell cycle and cell elongation related genes**. ^\*^Indicates *P* \< 0.05, Student\'s *t*-test; Error bars indicate SE.](fpls-08-00441-g0009){#F9}

Expression of hormone-related genes
-----------------------------------

Based on the observed effect of plant hormones on growth, the expression of hormone-related genes was also examined (Figure [10](#F10){ref-type="fig"}). The expression of the *GA2ox* gene, which catalyzes the catabolism of bioactive GA or their precursors, was significantly higher in YF than in CF. In addition, the GA signal transduction gene, *MdRGA*, which negatively regulates GA response, was also more highly expressed in YF than in CF, especially at 80 and 105 DABB. The expression of the cytokinin synthesis gene, *MdIPT9*, was significantly lower in YF than in CF during the period of rapid growth at 45, 65, 125, and 145 DABB. The *MdCKX5* gene, which is involved in the breakdown and catabolism of cytokinin, was upregulated to a higher level in YF than in CF at 45 and 65 DABB. The expression of the ABA synthesis gene, *MdNCED3*, was significantly lower in YF than in CF at 65 and 85 DABB, but higher in YF than in CF at 105 DABB.

![**Expression of hormone related genes**. ^\*^Indicates *P* \< 0.05, Student\'s *t*-test; Error bars indicate SE.](fpls-08-00441-g0010){#F10}

Effect of GA on shoot growth and miRNA expression
-------------------------------------------------

Auxin and GA~4+7~ was applied to YF and CF trees. Results indicated that the application of GA promoted shoot growth and internode elongation in YF trees (Figure [11A](#F11){ref-type="fig"}). The terminal shoot started to grow rapidly 1 week after the GA treatment was applied (Figure [11B](#F11){ref-type="fig"}). In total, internode length in YF trees increased by about 33% after the GA treatment, however, this was still less than the internode length in CF trees (Figure [11A](#F11){ref-type="fig"}). The auxin application did not stimulate shoot growth in either YF or CF trees (data not shown).

![**Effect of GA treatment on shoot and internode growth. (A)** Effect of GA treatment on internode length. **(B)** Effect of GA treatment on shoot growth. ^\*^Indicates *P* \< 0.05, Student\'s *t*-test; Error bars indicate SE.](fpls-08-00441-g0011){#F11}

The GA treatment dramatically downregulated miRNA166 expression (Figure [12](#F12){ref-type="fig"}). The potential target of miRNA166, *MdHD-ZIP*, was also downregulated during the first 2 days after the GA treatment. After the 6th day, however, *MdHD-ZIP* was upregulated. During the first 4 days after the GA treatment, the expression of miRNA164 in CF and YF trees was slightly upregulated. Then miRNA164 was downregulated in CF, but upregulated in YF. The expression of miRNA171 in YF trees exhibited little response to the GA treatment. The expression of miRNA171 in CF trees was upregulated on the 8th day after the application of the GA treatment. The expression of miRNA159 in both YF and CF trees showed little response to the GA treatment during the first 6 days, however, on the 8th day, the miRNA159 was upregulated in CF trees but downregulated in YF trees. Relative to the expression levels in CF trees, miRNA396 expression in YF trees slowly went down after the application of the GA treatment. The expression of miRNA167 exhibited little response during the first 2 days after the GA application but was downregulated on the 6th day, and then subsequently upregulated.

![**Expression of key miRNA after GA spraying**. ^\*^Indicates *P* \< 0.05, Student\'s *t*-test; Error bars indicate SE.](fpls-08-00441-g0012){#F12}

Discussion {#s4}
==========

YF is a natural spur mutant. YF trees have short internodes and reduced shoot length. Whether or not spur-type apple trees are also a fruiting characteristics, has been a source of debate, especially since the spur type phenotype of siblings derived from the spur-type apple exhibiting great variability (Fideghelli et al., [@B14]). Regardless, spur-type apple cultivars undoubtedly moderately reduced tree size as compared to standard-type trees (Costes et al., [@B9]). Unlike dwarfing rootstocks that reduce the proportion of lateral buds that develop into long shoots during the early development of trees (Lauri and Trottier, [@B26]; Seleznyova et al., [@B41]), YF produces a dwarf tree architecture by reducing the duration of shoot vegetative growth and shortening internode length.

In the present study, YF trees were demonstrated to contain lower levels of GA, ZR, IAA, and ABA. An application of GA promoted cell division in the shoot apical meristem and an increase in internode elongation in YF trees (Figures [11A,B](#F11){ref-type="fig"}). In contrast, YF trees exhibited no response to IAA. Previous studies have reported that the application of 6-benzylaminopurine and GA to apple nursery trees increased shoot elongation to a much greater extent than applying 6-benzylaminopurine alone (Zhang et al., [@B53]; Doric et al., [@B12]). Hence, among the hormones, GA, ZR, IAA, and ABA, it appears that GA plays a major role in YF trees.

The miRNA sequencing conducted in the present study confirmed the presence of 202 known miRNAs expression in apple shoot tips and discovered an additional 498 novel miRNAs. A total of 42 known miRNAs and 93 novel miRNAs were differentially expressed in the shoot tips of CF and YF trees. The differential expression of the miRNAs appeared to be related to the differences in shoot development observed in the two genotypes. This supports the premise that miRNAs are involved in the regulation of shoot architecture in YF trees.

Internode length and the number of nodes are two essential components that determine plant height. Compared to internode length, however, the impact of shoot apical meristem activity has a greater effect on shoot development. For example, the shoot apical meristem is responsible for terminating cell division when trees enter dormancy or when the vegetative meristem is converted to a floral meristem. The number of nodes is also determined by continued cell divisions in the shoot apical meristem. Therefore, factors affecting SAM development would also affect the number of nodes produced on a shoot during an annual growth cycle. Our results indicate that miRNA164, miRNA166, and miRNA171 are potentially involved in SAM development and differentially expressed in YF vs. CF apple shoot tips. A degradation of the NAC-domain transcription factors, CUC1 and CUC2 (Mallory et al., [@B32]; Raman et al., [@B38]) by miRNA164 has been reported to constrain the expansion of the boundary domain by degrading the NAC-domain transcription factors, CUC1 and CUC2 (Mallory et al., [@B32]; Raman et al., [@B38]). In *Arabidopsis*, CUC1, CUC2, and CUC3 function redundantly in initiating SAM and establishing organ boundaries (Aida et al., [@B2]). Abolishing miR164 regulation of CUC2 resulted in progressive enlargement of the boundary domain (Raman et al., [@B38]). The shoot tips in YF trees exhibited abnormal shoot tips, with the dome of the apex appearing a little larger than the apical dome in CF trees. This phenotype is also present in apples with columnar architecture and in some dwarfing rootstocks (Petersen and Krost, [@B37]). The *mir164abc* mutant frequently displayed extremely short internodes, small floral organs, and reduced fertility. Thus, miRNA164 may be involved in abnormal shoot and internode development in YF trees.

Among all of the miRNAs, miRNA166 had the highest level of expression in the shoot tips. miRNA166 potentially inhibited SAM development by targeting a set of HD-ZIP transcription factors that are important for maintaining pluripotency in shoot apical meristems (Williams et al., [@B46]). AGO10 binds miRNA165/166 to prevent its association with the broadly expressed AGO1 and thus prevents the degradation of HD-ZIP transcription factors in the SAM (Zhou et al., [@B55]). YF trees have a high proportion of spur shoots. Many of the lateral shoots in YF trees stopped elongating soon after bud break. Thus, miRNA166 may be involved in apple regulating the spur shoot habit in apple trees.

miRNA171 potentially targets the HAM subfamily genes, *SCL6-II, SCL6-III*, and *SCL6-IV*, within the *GRAS* gene family. miRNA171 affects the maintenance of SAM indeterminacy by regulating the shoot apical meristem WUS-CLV feedback loop (Schulze et al., [@B40]). The expression level of miRNA171 was significantly lower in YF trees than in CF trees. The height of *Arabidopsis* plants overexpressing miR171c was significantly higher than wild-type plants (Long et al., [@B31]). Upregulation of OsMIR171c in a delayed heading mutant rice genotype exhibited pleiotropic phenotypic defects, including a prolonged vegetative phase and a delayed heading date (Fan et al., [@B13]). These observations correspond to the reduced growth in YF shoots, relative to shoot growth in CF trees, and the earlier date in which growth ceased in YF trees, relative to CF trees.

As a result, it appears that the final internode phenotype results from an interplay between cell division and elongation that progresses in an inverse directions. Cell number has a more predominant role in regulating the growth and development of internodes because of cell length increases only two to three times, but cell numbers increase by 10 to 30 times (Pallardy, [@B36]). Analysis of the expression pattern of cell cycle genes further supports the premise that the SAM in YF trees has a lower rate of cell division than in CF trees (Figure [12](#F12){ref-type="fig"}). The expression of *MdCYCD, MdCYCB1;2, MdCYCD1;3*, and *MdRBR1* was significantly lower in YF shoot tips than in CF shoot tips. The period of high expression of the cell cycle genes corresponded to the period of rapid shoot growth; suggesting that cell division may play an instrumental role in shoot growth, and more so than cell elongation. Ripetti et al. ([@B39]) also found that genetic variation in internode length could be primarily attributed to cell numbers, while cell length played more of a secondary role. The miRNA sequencing and GO annotation in the present study identified several miRNAs related to cell division.

miRNA159 potentially deregulates its target genes, MYB33 and MYB65, in vegetative tissues, and inhibit growth by reducing cell proliferation (Alonso-Peral et al., [@B3]). The expression of miRNA159 was significantly higher in CF shoot tips than in YF shoot tips. The miRNA159 loss of function mutant, *mir159ab*, has an enlarged shoot apical meristem and smaller lateral organs (Alonso-Peral et al., [@B3]). miRNA159 and its targets have also been reported to be involved in GA-mediated flowering (Gocal et al., [@B17]; Achard et al., [@B1]). The expression of miRNA159 in YF shoot tips exhibited little response to the application of GA during the first 6 days after spraying GA. Interestingly, miR159a and miR159b also remained unchanged after the application of GA in wild-type *Arabidopsis* (Alonso-Peral et al., [@B3]). The potential target gene of miR159a, MYB65, however, was downregulated after the application of GA in *Malus domestica*. Thus, GA maybe regulate the expression of the target of miRNA159 to produce the miRNA159 phenotype.

miRNA396 negatively regulates its potential target gene, GROWTH RESPONDING FACTOR (GRF), to affect cell division in shoot meristems, leaves, and roots. miRNA396 appears to act as a strict repressor of the GA and CK pathways, and negatively regulates cell proliferation by decreasing cell division activity and the expression of cell cycle-related genes (Wang et al., [@B45]). The potential downregulation of the GA pathway genes by miR396 corresponds to the dwarf phenotype observed in miR396 overexpressing lines (Liu et al., [@B29]). The high level of expression of miRNA396 in YF shoot tips may inhibit cell division and internode elongation. miRNA396 was downregulated after GA application. Thus, GA may affect downstream GA response by downregulating miRNA396.

miRNA167 regulates vegetative and reproductive growth by controlling the expression of auxin response factors 6 and 8 (ARF6/8) in plants. Overexpression of miRNA167a results in twisted leaves, short inflorescences, and arrested flower development; thereby fully producing the mature phenotype of arf6arf8 plants (Wu et al., [@B48]). The expression of miRNA167 was significantly higher in YF shoot tips than in CF shoot tips. GA treatment downregulated miRNA167 at first, and then subsequently induced it; resulting in upregulating. But GA also increased the expression of the target gene, ARF6. DELLA has been reported to interact with ARF6 and inhibit ARF6 DNA-binding to modulate ARF6 gene expression (Oh et al., [@B35]). Hence, GA may promote cell elongation mechanisms in YF trees that involve miRNA167-ARF-mediated responses.

Based upon the findings of the current study, we present a model to explain how plant hormones and miRNA are involved in regulating the shoot development in spur-type YF trees (Figure [13](#F13){ref-type="fig"}). Low levels of IAA, GA, and CK are associated with reduced shoot growth in YF trees. GA appears to play a major role in regulating shoot development. Low levels of GA in YF shoots may reduce the number of cell divisions in the SAM, relative to the SAM in CF shoots, thus causing shoot growth to cease much earlier in the YF trees as compared to in the CF trees. In the model, low expression of miRNA164, miRNA171, and high expression of miRNA166 and their potential target genes affected SAM development and reduced the duration of shoot growth in YF trees. Of the three miRNAs, the regulation of miRNA166 by GA appeared to play a major role in shoot tips elongation in YF trees. The high levels of expression of miRNA167 and miRNA396, and the low expression of miRNA159, in YF trees appears to have inhibited cell division and reduced internode length. The results of the present study, and the hypothetical model presented, contributes to a better understanding of shoot development in perennial plants; especially those that exhibit a spur-type growth architecture.

![**Tentative model for the association of miRNAs with the phytohormone crosstalk regulation the spur type apple tree architecture**. Diagram represents a schematic drawing of an apple shoot apex. Arrows and inhibition lines linking the gene names represent positive and negative interactions, respectively. Up and down arrows behind the gene names represent up and down regulation, respectively.](fpls-08-00441-g0013){#F13}
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